Search

everythinglearnresearchcommunity

for

Search:↓

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Narrowband UVB treatment increases certain gene expressions in psoriasis skin and improves symptoms.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

People with Alopecia Areata are more likely to have prediabetes and obesity.

Melatonin may help treat PCOS symptoms in rats.

Lower SHBG levels may increase the risk of PCOS.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

High-intensity interval training improves certain hormone levels and lipid profiles in women with PCOS.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Melanoma patients can learn to check their skin, early balding in men may indicate similar risks as PCOS in women, certain criteria can help predict skin cancer behavior, small skin cancer may not need extra therapy after surgery, and sterile gloves don't reduce infection in minor surgeries.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Eating a high inositol diet significantly improves insulin resistance and hormone levels in women with PCOS.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

People with alopecia areata have higher insulin resistance.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Early balding men may have insulin resistance, but lifestyle changes can help.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.